Abstract:Gene therapy has long held promise to correct a variety of human diseases and defects. Discovery of the Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR), the mechanism of the CRISPR-based prokaryotic adaptive immune system (CRISPR-associated system, Cas), and its repurposing into a potent gene editing tool has revolutionized the field of molecular biology and generated excitement for new and improved gene therapies. Additionally, the simplicity and flexibility of the CRISPR/Cas9 site-specific nuclease system has led to its widespread use in many biological research areas including development of model cell lines, discovering mechanisms of disease, identifying disease targets, development of transgene animals and plants, and transcriptional modulation. In this review, we present the brief history and basic mechanisms of the CRISPR/Cas9 system and its predecessors (ZFNs and TALENs), lessons learned from past human gene therapy efforts, and recent modifications of CRISPR/Cas9 to provide functions beyond gene editing. We introduce several factors that influence CRISPR/Cas9 efficacy which must be addressed before effective in vivo human gene therapy can be realized. The focus then turns to the most difficult barrier to potential in vivo use of CRISPR/Cas9, delivery. We detail the various cargos and delivery vehicles reported for CRISPR/Cas9, including physical delivery methods (e.g. microinjection; electroporation), viral delivery methods (e.g. adeno-associated virus (AAV); full-sized adenovirus and lentivirus), and non-viral delivery methods (e.g. liposomes; polyplexes; gold particles), and discuss their relative merits. We also examine several technologies that, while not currently reported for CRISPR/Cas9 delivery, appear to have promise in this field. The therapeutic potential of CRISPR/Cas9 is vast and will only increase as the technology and its delivery improves.

The use of CRISPR/Cas associated technologies for cell transplant applications

Xenotransplantation: The Contribution of CRISPR/Cas9 Gene Editing Technology

Development and application of CRISPR/Cas9 technologies in genomic editing.

Xenogeneic transplantation and tolerance in the era of CRISPR-Cas9

Delivering CRISPR: a review of the challenges and approaches

CRISPR innovations in tissue engineering and gene editing

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

CRISPR/Cas system: An emerging technology in stem cell research

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases

CRISPR/Cas9-mediated genome editing: from basic research to gene therapy

Gene editing advance re-ignites debate on the merits and risks of animal to human transplantation

Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapy

Using CRISPR-Cas9 for Therapeutic Protein Production (Review Article)

The Applications of the CRISPR/Cas9 Gene-Editing System in Treating Human Diseases

CRISPR/Cas9 Mechanism and Applications Progression

CRISPR/Cas9‐mediated genome editing: From basic research to translational medicine

Delivery of CRISPR/Cas9 by novel strategies for gene therapy.

Applications of CRISPR technologies in transplantation

Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies

Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells

CRISPR-Cas System: The Current and Emerging Translational Landscape